AQS3pro: a cutting edge addition to the bioanalytical technologies showcased at WCBP 2019

The WCBP Symposium series was created to address issues at the interface of analytical development and global regulatory for biotechnology-derived health intervention products. The goal was to provide a forum for discussing the latest bioanalytical methods and their practical application to biotechnology pharmaceuticals and other health related products.

Our AQS3proTM  was a cutting edge addition to the new and existing technologies being showcased.  This included both method and instrumental advances that are used for product characterization, process development, in-process analysis and validate release and stability testing.
Interested in learning more about how the AS3pro fits into the technology landscape?

Biopharm International magazine recently published a roundtable with scientists experienced in biophysical characterization techniques on the range of technologies available for protein studies.

We look forward to seeing you at an upcoming conference.